U.S. Congress legislation · 119th Congress
SB5554: Ovarian Cancer IMPACT Act
Status: In committee, September 24, 2026
A bill to modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
What the bill says
To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
From the introduced text, September 24, 2026:
A BILL To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes. SECTION 1. Short title This Act may be cited as the Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing Act or the Ovarian Cancer IMPACT Act . SECTION 2. Findings Congress finds the following: (1) Ovarian cancer remains one of the deadliest gynecologic cancers and is frequently diagnosed at an advanced stage. (2) Early recognition of symptoms, access to genetic counseling and testing, and timely referral to specialized care can improve outcomes for individuals diagnosed with ovarian cancer. (3) Significant disparities persist in access to gynecologic oncology services, genetic counseling, hereditary cancer risk assessment, and specialty care, particularly in rural and medically underserved communities. (4) Advances in genetic and genomic science present significant opportunities to improve prevention, early detection, treatment selection, and survivorship outcomes. (5) Hereditary cancer syndromes, including hereditary breast and ovarian cancer syndrome and Lynch syndrome, contribute significantly to ovarian cancer risk and may first be identified following a diagnosis of endometrial cancer. (6) Evidence-based genetic counseling and testing can inform treatment decisions, guide preventive interventions, and identify at-risk family members who may benefit from surveillance or risk-reducing care. (7) Increased public education, provider …
Sponsors
- Slotkin, Elissa (D) · primary sponsor
- Katie Boyd Britt (R, SD-AL)
Latest actions
- : Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- : Introduced in Senate
Subjects: Health
Common questions
- What is SB5554?
- SB5554 is a bill in Congress (119th Congress): Ovarian Cancer IMPACT Act.
- What does SB5554 do?
- In its own words: To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
- What is the status of SB5554?
- In committee as of September 24, 2026. Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (September 24, 2026).
- Who sponsored SB5554?
- Slotkin, Elissa (D), with 1 co-sponsor.
- Where is the official record for SB5554?
- On the Congress website: https://www.congress.gov/bill/119th-congress/senate-bill/5554
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.